---
document_datetime: 2023-09-21 18:05:52
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/trudexa-epar-all-authorised-presentations_en.pdf
document_name: trudexa-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.6338227
conversion_datetime: 2025-12-22 17:01:45.788468
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number                    | Invented name   | Strength   | Pharmaceutical Form            | Route of Administration    | Packaging                         | Content   | Package size                                          |
|------------------------------|-----------------|------------|--------------------------------|----------------------------|-----------------------------------|-----------|-------------------------------------------------------|
| EU/1/03/257/001              | Trudexa         | 40 mg      | Solution for injection         | Subcutaneous use           | vial (glass)                      | 0.8 ml    | authorised 1 vial + 1 syringe +                       |
| EU/1/03/257/002              | Trudexa         | 40 mg      | Solution for injection         | Subcutaneous use           | pre-filled syringe (glass)        | 0.8 ml    | 2 alcohol pads 1 pre-filled syringe + 1 alcohol pad   |
| EU/1/03/257/003              | Trudexa         | 40 mg      | Solution for injection         | Subcutaneous use           | pre-filled syringe (glass)        | 0.8 ml    | 2 pre-filled syringes + 2 alcohol pads                |
| EU/1/03/257/004              | Trudexa         | 40 mg      | Solution for injection         | Subcutaneous use           | pre-filled syringe (glass)        | 0.8 ml    | 4 pre-filled syringes + 4 alcohol pads                |
| EU/1/03/257/005              | Trudexa         | 40 mg      | Solution for injection         | Subcutaneous use           | pre-filled syringe (glass)        | 0.8 ml    | 6 pre-filled syringes + 6 alcohol pads                |
| EU/1/03/257/006              | Trudexa         | 40 mg      | Solution for injection         | Subcutaneous use           | longer pre-filled syringe (glass) | 0.8 ml    | 1 pre-filled syringe with needleguard + 1 alcohol pad |
| EMEA Number                  | Invented name   | Strength   | Pharmaceutical Form            | no Route of Administration | Packaging                         | Content   | Package size                                          |
| EMEA/H/C/000482/II/0030/ 007 | Trudexa         | 40 mg      | Product Solution for injection | Subcutaneous use           | pre-filled pen (glass)            | 0.8 ml    | 1 pre-filled pen + 1 alcohol pad in a blister         |
| EMEA/H/C/000482/II/0030/ 008 | Trudexa         | 40 mg      | Solution for injection         | Subcutaneous use           | pre-filled pen (glass)            | 0.8 ml    | 2 pre-filled pens + 2 alcohol pads in a blister       |
| EMEA/H/C/000482/II/0030/ 009 | Trudexa         | 40 mg      | Solution for injection         | Subcutaneous use           | pre-filled pen (glass)            | 0.8 ml    | 4 pre-filled pens + 4 alcohol pads in a blister       |
| EMEA/H/C/000482/II/0030/ 010 | Trudexa         | 40 mg      | Solution for injection         | Subcutaneous use           | pre-filled pen (glass)            | 0.8 ml    | 6 pre-filled pens + 6 alcohol pads in a blister       |

Medicinal Product no longer authorised